首页> 外文期刊>International Journal of Advances in Pharmaceutical Research >DESIGN AND CHARACTERIZATION OF MATRIX TYPE TRANSDERMAL DRUG DELIVERY SYSTEM USING METOPROLOL TARTARATE
【24h】

DESIGN AND CHARACTERIZATION OF MATRIX TYPE TRANSDERMAL DRUG DELIVERY SYSTEM USING METOPROLOL TARTARATE

机译:酒石酸甲羟丙酸酯基质型经皮药物输送系统的设计与表征。

获取原文
获取外文期刊封面目录资料

摘要

Transdermal drug delivery is an alternative route for systemic drug delivery which minimizes the absorption and increases the bioavailability. Oral Metoprolol tartrate has a short elimination half life (2-3 hrs), low bioavailability (35 %) undergoes extensive first pass metabolism and frequent high doses (100 mg two divided doses for 24 hrs) are required to maintain the therapeutic level as a result, dose development toxic side effects are frequently observed, so has chosen as transdermal drug delivery system. The present study was to design and characterize transdermal drug delivery system of Metoprolol tartrate using various polymers such as HPMC, PVP by solvent casting technique. Propylene glycol (30% v/v) used as a plasticizer. The prepared formulation were evaluated for different physicochemical characteristics like thickness, folding endurance, drug content, percentage moisture absorption, percentage moisture loss and weight uniformity. The drug release characteristics of the formulation were studied in In-vitro conditions by using artificial semi-permeable membrane. In-vitro dissolution studies were performed in phosphate buffer (7.4 pH) for 12 hrs by using keshery chein apparatus. The in-vitro drug release plot has shown that the drug release followed zero order kinetics, which was evidenced from the regression value. Based on the drug release and physicochemical values obtained the formulation M VI is considered as an optimized formulation which shows higher percentage of drug release (98.92 % at 12 hour) with non-fickian type diffusion mediated mechanism.
机译:透皮药物递送是全身性药物递送的替代途径,其使吸收最小化并增加了生物利用度。酒石酸美托洛尔口服液的消除半衰期短(2-3小时),低生物利用度(35%)经历大量的首过代谢,需要频繁的大剂量服用(100毫克,分两次服用24小时),以维持治疗水平。结果,经常观察到剂量发展的毒副作用,因此选择了透皮给药系统。本研究旨在通过溶剂流延技术设计和表征酒石酸美托洛尔的透皮给药系统,该系统使用多种聚合物,如HPMC,PVP。丙二醇(30%v / v)用作增塑剂。评价了所制备的制剂的不同理化特性,例如厚度,耐折性,药物含量,吸湿率,水分损失率和重量均匀性。通过使用人造半透膜在体外条件下研究了该制剂的药物释放特性。体外溶出研究是通过使用keshery chein仪器在磷酸盐缓冲液(7.4 pH)中进行的12小时。体外药物释放曲线表明,药物释放遵循零级动力学,这从回归值得到了证明。基于所获得的药物释放和理化值,认为制剂M VI是优化的制剂,其显示出更高的药物释放百分比(12小时时为98.92%),且具有非菲克型扩散介导的机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号